KRYSTAL BIOTECH INC. news, videos and press releases
For more news please use our advanced search feature.
KRYSTAL BIOTECH INC. - More news...
KRYSTAL BIOTECH INC. - More news...
- Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
- Krystal Biotech to Present at TD Cowen 45th Annual Health Care Conference
- Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results
- Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
- Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer
- Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer
- Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels
- Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa
- Krystal Biotech to Present at Upcoming Investor Conferences
- Krystal Biotech to Present at Stifel 2024 Healthcare Conference
- Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
- Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates
- Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024
- Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference
- Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté
- Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates
- Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024
- Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
- Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
- Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
- Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates
- Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
- Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
- Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
- Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
- Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference
- Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
- Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
- Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung
